Top 18 ESCAPE Bio investors
The most complete profiles first. Showing 18 of 18.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Cleave Therapeutics18
- Delfi Diagnostics18
- ReCode Therapeutics18
- Q32 Bio18
- PMV Pharmaceuticals18
- Pandion Therapeutics10
- Edgewise Therapeutics10
- Caris Life Sciences10
- Janux Therapeutics10
- ImmPACT Bio USA10
- Ruipeng Pet Healthcare10
Frequently asked questions
How many ESCAPE Bio investors are on Angel Roster?
Angel Roster lists 18 ESCAPE Bio investors. 10 of them (56%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (14), Venture Capital Firms (13) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do ESCAPE Bio investors invest in?
Among those that list a stage, the most common are Series A (10) and Seed (5).
Where are ESCAPE Bio investors based?
Most are based in the United States (15), Israel (2) and China (1).
Which companies have ESCAPE Bio investors backed?
The most-backed portfolio companies among them are Cleave Therapeutics (18), Delfi Diagnostics (18), ReCode Therapeutics (18), Q32 Bio (18) and PMV Pharmaceuticals (18).
How do I contact ESCAPE Bio investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.